TREATMENT OPTIONS IN ONCOLOGY:@0.084848:0.038601:0.493541:0.038601:0.493541:0.019343:0.084848:0.019343:0.010019:0.014276:0.012606:0.015487:0.010019:0.021613:0.012606:0.017404:0.010019:0.006515:0.020438:0.013923:0.010019:0.005315:0.020438:0.017404:0.011712:0.006515:0.005315:0.017404:0.006515:0.020438:0.017404:0.019121:0.020438:0.010866:0.020438:0.020508:0.013923
12:@0.023705:0.038809:0.044778:0.038809:0.044778:0.019212:0.023705:0.019212:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.084848:0.970015:0.320957:0.970015:0.320957:0.956010:0.084848:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
with medium risk include doxorubicin and :@0.084848:0.096166:0.481107:0.096166:0.481107:0.080410:0.084848:0.080410:0.015990:0.003848:0.006523:0.011738:0.006254:0.018049:0.012508:0.013181:0.003848:0.011699:0.018049:0.006254:0.005792:0.003848:0.007466:0.009660:0.006254:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.006254:0.013181:0.012604:0.009236:0.012604:0.005792:0.011699:0.013123:0.003848:0.012450:0.003848:0.011738:0.006254:0.013143:0.011738:0.013181:0.005330
platinum compounds, including cisplatin :@0.084848:0.112557:0.481069:0.112557:0.481069:0.096801:0.084848:0.096801:0.013123:0.003848:0.013143:0.006523:0.003848:0.011738:0.011699:0.018049:0.009794:0.012450:0.012604:0.018049:0.013123:0.012604:0.011699:0.011738:0.013181:0.007466:0.005330:0.009794:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.003848:0.011738:0.012950:0.009794:0.012450:0.003848:0.007466:0.013123:0.003848:0.013143:0.006523:0.003848:0.011738:0.005330
and carboplatin.  Drugs  with low risk of :@0.084848:0.128947:0.481114:0.128937:0.481114:0.113181:0.084848:0.113192:0.013143:0.011738:0.013181:0.009602:0.012450:0.013143:0.005792:0.013123:0.012604:0.013123:0.003848:0.013143:0.006523:0.003848:0.011738:0.005330:0.012428:0.009602:0.014316:0.005792:0.011699:0.012950:0.007466:0.005330:0.004262:0.015990:0.003848:0.006523:0.011738:0.009602:0.003848:0.012604:0.015990:0.009602:0.005792:0.003848:0.007466:0.009660:0.009602:0.012604:0.006042:0.814133
37:@0.247171:0.123318:0.259601:0.123318:0.259601:0.114132:0.247171:0.114132:0.006215:0.006215
gonadal  toxicity  include  vincristine,  vin-:@0.084846:0.145328:0.475746:0.145328:0.475746:0.129572:0.084846:0.129572:0.012950:0.012604:0.011738:0.013143:0.013181:0.013143:0.003848:0.005330:0.006490:0.006523:0.012604:0.009236:0.003848:0.012450:0.003848:0.006523:0.010314:0.005330:0.006494:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.005330:0.006494:0.010660:0.003848:0.011738:0.012450:0.005792:0.003848:0.007466:0.006523:0.003848:0.011738:0.012508:0.005330:0.005330:0.006489:0.010660:0.003848:0.011738:0.006388
blastine, bleomycin, dactinomycin, and :@0.084846:0.161719:0.481105:0.161719:0.481105:0.145963:0.084846:0.145963:0.013123:0.003848:0.013143:0.007466:0.006523:0.003848:0.011738:0.012508:0.005330:0.012103:0.013123:0.003848:0.012508:0.012604:0.018049:0.010314:0.012450:0.003848:0.011738:0.005330:0.012103:0.013181:0.013143:0.012450:0.006523:0.003848:0.011738:0.012604:0.018049:0.010314:0.012450:0.003848:0.011738:0.005330:0.012103:0.013143:0.011738:0.013181:0.005330
antimetabolites such as methotrexate, :@0.084846:0.178110:0.481089:0.178110:0.481089:0.162354:0.084846:0.162354:0.013143:0.011738:0.006523:0.003848:0.018049:0.012508:0.006523:0.013143:0.013123:0.012604:0.003848:0.003848:0.006523:0.012508:0.007466:0.016221:0.007466:0.011699:0.012450:0.011738:0.016221:0.013143:0.007466:0.016221:0.018049:0.012508:0.006523:0.011738:0.012604:0.006523:0.005700:0.012508:0.009236:0.013143:0.006523:0.012508:0.005330:0.005330
mercaptopurine,  and  5-fluorouracil.:@0.084846:0.194501:0.445545:0.194501:0.445545:0.178745:0.084846:0.178745:0.018049:0.012508:0.005653:0.012450:0.013143:0.013123:0.006523:0.012604:0.013123:0.011699:0.005792:0.003848:0.011738:0.012508:0.005330:0.005330:0.014382:0.013143:0.011738:0.013181:0.005330:0.014391:0.010660:0.006388:0.004666:0.004666:0.011699:0.012604:0.005713:0.012604:0.011699:0.005792:0.013143:0.012450:0.003848:0.003848:0.005330
37, 38  :@0.445539:0.188861:0.478855:0.188861:0.478855:0.179675:0.445539:0.179675:0.006215:0.006215:0.003107:0.002242:0.006215:0.006215:0.000000:0.003107
Female infertility as a result of chemother-:@0.084848:0.210865:0.475758:0.210865:0.475758:0.195109:0.084848:0.195109:0.009333:0.012508:0.018049:0.013143:0.003848:0.012508:0.006042:0.003848:0.011738:0.006042:0.012508:0.005792:0.006523:0.003848:0.003848:0.003848:0.006523:0.010314:0.006042:0.013143:0.007466:0.006042:0.013143:0.006042:0.005713:0.012508:0.007466:0.011699:0.003848:0.006523:0.006042:0.012604:0.006042:0.006042:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005775:0.006388
apy appears to be secondary to prema-:@0.084848:0.227256:0.475771:0.227256:0.475771:0.211500:0.084848:0.211500:0.013143:0.013123:0.010314:0.007351:0.013143:0.013123:0.013123:0.012508:0.013143:0.005792:0.007466:0.007341:0.006523:0.012604:0.007337:0.013123:0.012508:0.007339:0.007466:0.012508:0.012450:0.012604:0.011738:0.013181:0.013143:0.005792:0.010314:0.007339:0.006523:0.012604:0.007333:0.013123:0.005715:0.012508:0.018049:0.013143:0.006388
ture ovarian failure.:@0.084848:0.243647:0.265005:0.243647:0.265005:0.227891:0.084848:0.227891:0.006523:0.011699:0.005707:0.012508:0.005330:0.012604:0.010660:0.013143:0.005792:0.003848:0.013143:0.011738:0.005330:0.006042:0.013143:0.003848:0.003848:0.011699:0.005713:0.012508:0.005330
36:@0.265002:0.238018:0.277432:0.238018:0.277432:0.228832:0.265002:0.228832:0.006215:0.006215
TERATOGENICITY:@0.084848:0.276731:0.255892:0.276731:0.255892:0.258916:0.084848:0.258916:0.008980:0.011118:0.012401:0.015822:0.008980:0.017960:0.017960:0.011118:0.015822:0.005987:0.016677:0.005987:0.008980:0.013256
Chemotherapy  treatment  is teratogenic :@0.084848:0.294263:0.481103:0.294263:0.481103:0.278507:0.084848:0.278507:0.015644:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.005369:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.005371:0.003848:0.007466:0.010718:0.006523:0.012508:0.005792:0.013143:0.006523:0.012604:0.012950:0.012508:0.011738:0.003848:0.012450:0.005330
during  pregnancy,  especially  during  the :@0.084848:0.310654:0.481098:0.310654:0.481098:0.294898:0.084848:0.294898:0.013181:0.011699:0.005792:0.003848:0.011738:0.012950:0.005330:0.004580:0.013123:0.005715:0.012508:0.012950:0.011738:0.013143:0.011738:0.012450:0.010314:0.005330:0.005330:0.004584:0.012508:0.007466:0.013123:0.012508:0.012450:0.003848:0.013143:0.003848:0.003848:0.010331:0.005330:0.004587:0.013181:0.011699:0.005792:0.003848:0.011738:0.012950:0.005330:0.004580:0.006523:0.011738:0.012508:0.005330
first trimester.  During the second and third :@0.084848:0.327045:0.481086:0.327045:0.481086:0.311289:0.084848:0.311289:0.004686:0.004686:0.005792:0.007466:0.006523:0.005532:0.006523:0.005792:0.003848:0.018049:0.012508:0.007466:0.006523:0.012508:0.004372:0.005330:0.005538:0.005540:0.014316:0.011699:0.005792:0.003848:0.011738:0.012950:0.005534:0.006523:0.011738:0.012508:0.005532:0.007466:0.012508:0.012450:0.012604:0.011738:0.013181:0.005536:0.013143:0.011738:0.013181:0.005540:0.006523:0.011738:0.003848:0.005673:0.013181:0.005330
trimesters, chemotherapy exposure is not :@0.084848:0.343436:0.481101:0.343436:0.481101:0.327680:0.084848:0.327680:0.006523:0.005792:0.003848:0.018049:0.012508:0.007466:0.006523:0.012508:0.005792:0.007466:0.005330:0.007893:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.007893:0.012508:0.009236:0.013123:0.012604:0.007466:0.011699:0.005711:0.012508:0.007899:0.003848:0.007466:0.007909:0.011738:0.012604:0.006523:0.005330
associated with an increase in teratogen-:@0.084848:0.359827:0.475758:0.359827:0.475758:0.344071:0.084848:0.344071:0.013143:0.007466:0.007466:0.012604:0.012450:0.003848:0.013143:0.006523:0.012508:0.013181:0.006004:0.015990:0.003848:0.006523:0.011738:0.005994:0.013143:0.011738:0.005994:0.003848:0.011738:0.012450:0.005713:0.012508:0.013143:0.007466:0.012508:0.006004:0.003848:0.011738:0.006004:0.006523:0.012508:0.005792:0.013143:0.006523:0.012604:0.012950:0.012508:0.011701:0.006388
ic risk.:@0.084848:0.376218:0.138573:0.376218:0.138573:0.360462:0.084848:0.360462:0.003848:0.012450:0.005330:0.005792:0.003848:0.007466:0.009660:0.005330
39:@0.138573:0.370573:0.151003:0.370573:0.151003:0.361387:0.138573:0.361387:0.006215:0.006215
PERIPHERAL NEUROPATHY:@0.084848:0.409286:0.343124:0.409286:0.343124:0.391471:0.084848:0.391471:0.011973:0.011118:0.012401:0.005987:0.011973:0.014539:0.011118:0.012401:0.015822:0.009407:0.005987:0.015822:0.011118:0.013683:0.012401:0.017960:0.011973:0.015822:0.008980:0.014539:0.013256
Peripheral  neuropathy  occurs in  approxi-:@0.084848:0.426818:0.475771:0.426818:0.475771:0.411063:0.084848:0.411063:0.011392:0.012508:0.005792:0.003848:0.013123:0.011738:0.012508:0.005792:0.013143:0.003848:0.005330:0.002890:0.011738:0.012508:0.011699:0.005713:0.012604:0.013123:0.013143:0.006523:0.011738:0.010314:0.005330:0.002894:0.012604:0.012450:0.012450:0.011699:0.005780:0.007466:0.008236:0.003848:0.011738:0.005330:0.002896:0.013143:0.013123:0.013123:0.005721:0.012604:0.009236:0.003848:0.006388
mately 30 to 40 percent of patients treated :@0.084848:0.443209:0.481090:0.443209:0.481090:0.427453:0.084848:0.427453:0.018049:0.013143:0.006523:0.012508:0.003848:0.010314:0.003810:0.010660:0.010660:0.003810:0.006523:0.012604:0.003798:0.010660:0.010660:0.003810:0.013123:0.012508:0.005657:0.012450:0.012508:0.011738:0.006523:0.003798:0.012604:0.006042:0.003800:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.003810:0.006523:0.005711:0.012508:0.013143:0.006523:0.012508:0.013181:0.005330
with chemotherapy agents. Chemothera-:@0.084848:0.459600:0.475758:0.459600:0.475758:0.443844:0.084848:0.443844:0.015990:0.003848:0.006523:0.011738:0.005355:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012490:0.005792:0.013143:0.013123:0.010314:0.005359:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.005330:0.005349:0.015644:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013125:0.006388
py-induced peripheral neuropathy (CIPN), :@0.084848:0.475991:0.481099:0.475991:0.481099:0.460235:0.084848:0.460235:0.013123:0.010314:0.006388:0.003848:0.011738:0.013181:0.011699:0.012450:0.012508:0.013181:0.004272:0.013123:0.012508:0.005792:0.003848:0.013123:0.011738:0.012508:0.005792:0.013143:0.003848:0.004272:0.011738:0.012508:0.011699:0.005707:0.012604:0.013123:0.013143:0.006523:0.011738:0.010314:0.004272:0.007100:0.015644:0.004349:0.011392:0.014239:0.007100:0.005330:0.005330
is a progressive, and often  irreversible or :@0.084848:0.492382:0.481109:0.492382:0.481109:0.476626:0.084848:0.476626:0.003848:0.007466:0.008852:0.013143:0.008852:0.013123:0.005715:0.012604:0.012950:0.005705:0.012508:0.007466:0.007466:0.003848:0.010660:0.012519:0.005330:0.008852:0.013143:0.011738:0.013181:0.008852:0.012604:0.006042:0.006523:0.012508:0.011738:0.005330:0.003504:0.003848:0.005792:0.005713:0.012508:0.010660:0.012508:0.005792:0.007466:0.003848:0.013123:0.003848:0.012508:0.008852:0.012604:0.005792:0.005330
partially reversible condition. Symptoms :@0.084848:0.508773:0.481086:0.508773:0.481086:0.493017:0.084848:0.493017:0.013123:0.013143:0.005792:0.006523:0.003848:0.013143:0.003848:0.003848:0.010314:0.013258:0.005713:0.012508:0.010660:0.012508:0.005792:0.007466:0.003848:0.013123:0.003848:0.012508:0.013258:0.012450:0.012604:0.011738:0.013181:0.003848:0.006523:0.003848:0.012604:0.011738:0.005330:0.013258:0.009583:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.007466:0.005330
include pain, tingling, numbness, and cold :@0.084848:0.525164:0.481088:0.525164:0.481088:0.509408:0.084848:0.509408:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.004483:0.013123:0.013143:0.003848:0.011738:0.005330:0.004483:0.006523:0.003848:0.011738:0.012950:0.003848:0.003848:0.011738:0.012950:0.005330:0.004483:0.011738:0.011699:0.018049:0.013123:0.011738:0.012508:0.007466:0.007466:0.005330:0.004483:0.013143:0.011738:0.013181:0.004483:0.012450:0.012604:0.003848:0.013181:0.005330
sensitivity in the hands and feet.  Agents :@0.084848:0.541555:0.481104:0.541518:0.481104:0.525762:0.084848:0.525799:0.007466:0.012508:0.011738:0.007466:0.003848:0.006523:0.003848:0.010660:0.003848:0.006523:0.010314:0.007293:0.003848:0.011738:0.007293:0.006523:0.011738:0.012508:0.007279:0.011738:0.013143:0.011738:0.013181:0.007466:0.007293:0.013143:0.011738:0.013181:0.007293:0.006042:0.012508:0.012508:0.006523:0.005330:0.012422:0.007293:0.014239:0.012950:0.012508:0.011738:0.006523:0.007466:0.214026
40:@0.390623:0.535899:0.403052:0.535899:0.403052:0.526714:0.390623:0.526714:0.006215:0.006215
associated with CIPN include vinca alka-:@0.084845:0.557909:0.475728:0.557909:0.475728:0.542153:0.084845:0.542153:0.013143:0.007466:0.007466:0.012604:0.012450:0.003848:0.013143:0.006523:0.012508:0.013181:0.007516:0.015990:0.003848:0.006523:0.011738:0.007505:0.015644:0.004349:0.011392:0.014239:0.007505:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.007505:0.010660:0.003848:0.011738:0.012450:0.013143:0.007505:0.013143:0.003848:0.009660:0.013143:0.006388
loids (vincristine), taxanes (paclitaxel and :@0.084845:0.574300:0.481065:0.574300:0.481065:0.558544:0.084845:0.558544:0.003848:0.012604:0.003848:0.013181:0.007466:0.007351:0.007100:0.010660:0.003848:0.011738:0.012450:0.005792:0.003848:0.007466:0.006523:0.003848:0.011738:0.012508:0.007100:0.005330:0.007351:0.006523:0.013143:0.009236:0.013143:0.011738:0.012508:0.007466:0.007351:0.007100:0.013123:0.013143:0.012450:0.003848:0.003848:0.006523:0.013143:0.009236:0.012508:0.003848:0.007351:0.013143:0.011738:0.013181:0.005330
docetaxel), proteasome  inhibitors (bort-:@0.084845:0.590691:0.475764:0.590691:0.475764:0.574935:0.084845:0.574935:0.013181:0.012604:0.012450:0.012508:0.006523:0.013143:0.009236:0.012508:0.003848:0.007100:0.005330:0.012065:0.013123:0.005715:0.012604:0.006523:0.012508:0.013143:0.007466:0.012604:0.018049:0.012508:0.005330:0.006725:0.003848:0.011738:0.011738:0.003848:0.013123:0.003848:0.006523:0.012604:0.005792:0.007466:0.012065:0.007100:0.013123:0.012604:0.005792:0.006523:0.006388
ezomib), and the  platinum-based drugs :@0.084845:0.607082:0.481092:0.607082:0.481092:0.591326:0.084845:0.591326:0.012508:0.008178:0.012604:0.018049:0.003848:0.013123:0.007100:0.005330:0.010622:0.013143:0.011738:0.013181:0.010622:0.006523:0.011738:0.012508:0.005330:0.005280:0.013123:0.003848:0.013143:0.006523:0.003848:0.011738:0.011699:0.018049:0.006388:0.013123:0.013143:0.007466:0.012508:0.013181:0.010622:0.013181:0.005792:0.011699:0.012950:0.007466:0.005330
(cisplatin  and oxaliplatin). Thalidomide :@0.084845:0.623473:0.481077:0.623473:0.481077:0.607717:0.084845:0.607717:0.007100:0.012450:0.003848:0.007466:0.013123:0.003848:0.013143:0.006523:0.003848:0.011738:0.005330:0.010768:0.013143:0.011738:0.013181:0.016087:0.012604:0.009236:0.013143:0.003848:0.003848:0.013123:0.003848:0.013143:0.006523:0.003848:0.011738:0.007100:0.005330:0.016087:0.008197:0.011738:0.013143:0.003848:0.003848:0.013181:0.012604:0.018049:0.003848:0.013181:0.012508:0.005330
is  another anticancer agent used in the :@0.084845:0.639864:0.481087:0.639864:0.481087:0.624108:0.084845:0.624108:0.003848:0.007466:0.005330:0.003706:0.013143:0.011738:0.012604:0.006523:0.011728:0.012508:0.005792:0.009025:0.013143:0.011738:0.006523:0.003848:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.009025:0.013143:0.012950:0.012508:0.011738:0.006523:0.009025:0.011699:0.007466:0.012508:0.013181:0.009025:0.003848:0.011738:0.009025:0.006523:0.011738:0.012508:0.005330
treatment  of multiple myeloma causing :@0.084845:0.656255:0.481087:0.656255:0.481087:0.640499:0.084845:0.640499:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.005607:0.012604:0.006042:0.010949:0.018049:0.011699:0.003848:0.006523:0.003848:0.013123:0.003848:0.012508:0.010949:0.018049:0.010314:0.012508:0.003848:0.012604:0.018049:0.013143:0.010949:0.012450:0.013143:0.011699:0.007466:0.003848:0.011738:0.012950:0.005330
peripheral neuropathy.:@0.084845:0.672646:0.310953:0.672646:0.310953:0.656890:0.084845:0.656890:0.013123:0.012508:0.005792:0.003848:0.013123:0.011738:0.012508:0.005792:0.013143:0.003848:0.016260:0.011738:0.012508:0.011699:0.005705:0.012604:0.013123:0.013143:0.006523:0.011738:0.010314:0.005330
40, 41:@0.310956:0.666984:0.341164:0.666984:0.341164:0.657799:0.310956:0.657799:0.006215:0.006215:0.003107:0.002242:0.006215:0.006215
 The severity :@0.341174:0.672603:0.481085:0.672603:0.481085:0.656847:0.341174:0.656847:0.016260:0.008197:0.011738:0.012508:0.016260:0.007466:0.012508:0.010660:0.012508:0.005792:0.003848:0.006523:0.010314:0.005330
of CIPN is determined by the particular :@0.084846:0.688994:0.481114:0.688994:0.481114:0.673238:0.084846:0.673238:0.012604:0.006042:0.010237:0.015644:0.004349:0.011392:0.014239:0.010237:0.003848:0.007466:0.010237:0.013181:0.012508:0.006523:0.012508:0.006321:0.018049:0.003848:0.011738:0.012508:0.013181:0.010237:0.013123:0.010314:0.010237:0.006523:0.011738:0.012508:0.010237:0.013123:0.013143:0.005792:0.006523:0.003848:0.012450:0.011699:0.003848:0.013143:0.005792:0.005330
chemotherapy drug used, the duration of :@0.084846:0.705385:0.481095:0.705385:0.481095:0.689629:0.084846:0.689629:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005728:0.013181:0.005792:0.011699:0.012950:0.005736:0.011699:0.007466:0.012508:0.013181:0.005330:0.005740:0.006523:0.011738:0.012508:0.005742:0.013181:0.011699:0.005792:0.013143:0.006523:0.003848:0.012604:0.011738:0.005734:0.012604:0.006042:0.005330
therapy and the total dose.  Cisplatin and :@0.084846:0.721776:0.481116:0.721776:0.481116:0.706020:0.084846:0.706020:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005426:0.013143:0.011738:0.013181:0.005426:0.006523:0.011738:0.012508:0.005426:0.006523:0.012604:0.006523:0.013143:0.003848:0.005426:0.013181:0.012604:0.007466:0.012508:0.005330:0.005426:0.005426:0.015644:0.003848:0.007466:0.013123:0.003848:0.013143:0.006523:0.003848:0.011738:0.005438:0.013143:0.011738:0.013181:0.005330
oxaliplatin  neuropathy may deteriorate :@0.084846:0.738167:0.481097:0.738167:0.481097:0.722411:0.084846:0.722411:0.012604:0.009236:0.013143:0.003848:0.003848:0.013123:0.003848:0.013143:0.006523:0.003848:0.011738:0.005330:0.008174:0.011738:0.012508:0.011699:0.005711:0.012604:0.013123:0.013143:0.006523:0.011738:0.010314:0.013489:0.018049:0.013143:0.010314:0.013489:0.013181:0.012508:0.006523:0.012508:0.005792:0.003848:0.012604:0.005792:0.013143:0.006523:0.012508:0.005330
several months after the treatment com-:@0.084846:0.754558:0.475778:0.754558:0.475778:0.738802:0.084846:0.738802:0.007466:0.012508:0.010660:0.012508:0.005792:0.013143:0.003848:0.007889:0.018049:0.012604:0.011738:0.006523:0.011738:0.007466:0.007889:0.013143:0.006042:0.006523:0.012508:0.005792:0.007874:0.006523:0.011738:0.012508:0.007874:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.007872:0.012450:0.012604:0.018049:0.006388
pletion.:@0.084846:0.770949:0.154369:0.770949:0.154369:0.755193:0.084846:0.755193:0.013123:0.003848:0.012508:0.006523:0.003848:0.012604:0.011738:0.005330
40, 43, 44:@0.154367:0.765298:0.202357:0.765298:0.202357:0.756113:0.154367:0.756113:0.006215:0.006215:0.003107:0.002243:0.006215:0.006215:0.003107:0.002243:0.006215:0.006215
  Neuropathic  pain can  be :@0.202369:0.770917:0.481090:0.770917:0.481090:0.755161:0.202369:0.755161:0.005330:0.007418:0.014239:0.012508:0.011699:0.005703:0.012604:0.013123:0.013143:0.006523:0.011738:0.003848:0.012450:0.005330:0.007416:0.013123:0.013143:0.003848:0.011738:0.012758:0.012450:0.013143:0.011738:0.005330:0.007416:0.013123:0.012508:0.005330
managed pharmacologically. However, :@0.084856:0.787308:0.481103:0.787308:0.481103:0.771552:0.084856:0.771552:0.018049:0.013143:0.011738:0.013143:0.012950:0.012508:0.013181:0.013470:0.013123:0.011738:0.013143:0.006323:0.018049:0.013143:0.012450:0.012604:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.003848:0.010314:0.005330:0.013470:0.013143:0.012604:0.015990:0.012508:0.010660:0.012508:0.003768:0.005330:0.005330
treatment of numbness is ineffective.:@0.084856:0.803699:0.427192:0.803699:0.427192:0.787943:0.084856:0.787943:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.012604:0.006042:0.005330:0.011738:0.011699:0.018049:0.013123:0.011738:0.012508:0.007466:0.007466:0.005330:0.003848:0.007466:0.005330:0.003848:0.011738:0.012508:0.006081:0.006042:0.012508:0.012450:0.006523:0.003848:0.010660:0.012508:0.005330
45:@0.427181:0.798070:0.439611:0.798070:0.439611:0.788884:0.427181:0.788884:0.006215:0.006215
TUMOR LYSIS SYNDROME:@0.084848:0.836783:0.335855:0.836783:0.335855:0.818968:0.084848:0.818968:0.008980:0.013683:0.019242:0.017960:0.012401:0.005987:0.009407:0.013256:0.011118:0.005987:0.011118:0.005987:0.011118:0.013256:0.015822:0.014966:0.012401:0.017960:0.019242:0.011118
Tumor  lysis syndrome  is a  condition  as-:@0.084848:0.854315:0.475746:0.854315:0.475746:0.838559:0.084848:0.838559:0.007310:0.011699:0.018049:0.012604:0.005792:0.005330:0.006483:0.003848:0.010314:0.007466:0.003848:0.007466:0.011834:0.007466:0.010314:0.011738:0.013181:0.005713:0.012604:0.018049:0.012508:0.005330:0.006487:0.003848:0.007466:0.011834:0.013143:0.005330:0.006494:0.012450:0.012604:0.011738:0.013181:0.003848:0.006523:0.003848:0.012604:0.011738:0.005330:0.006487:0.013143:0.007466:0.006388
sociated with the  breakdown  of  cancer :@0.084848:0.870706:0.481109:0.870706:0.481109:0.854950:0.084848:0.854950:0.007466:0.012604:0.012450:0.003848:0.013143:0.006523:0.012508:0.013181:0.009198:0.015990:0.003848:0.006523:0.011738:0.009198:0.006523:0.011738:0.012508:0.005330:0.003854:0.013123:0.005715:0.012508:0.013143:0.009660:0.013181:0.012604:0.015990:0.011738:0.005330:0.003858:0.012604:0.006042:0.005330:0.003854:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330
cells that causes the release of chemi-:@0.084848:0.887097:0.475754:0.887097:0.475754:0.871341:0.084848:0.871341:0.012450:0.012508:0.003848:0.003848:0.007466:0.011007:0.006523:0.011738:0.013143:0.006523:0.011007:0.012450:0.013143:0.011699:0.007466:0.012508:0.007466:0.011007:0.006523:0.011738:0.012508:0.011007:0.005711:0.012508:0.003848:0.012508:0.013143:0.007466:0.012508:0.011007:0.012604:0.006042:0.011007:0.012450:0.011738:0.012508:0.018049:0.003848:0.006388
cals from  the  intracellular compartment. :@0.084848:0.903488:0.481117:0.903488:0.481117:0.887732:0.084848:0.887732:0.012450:0.013143:0.003848:0.007466:0.009217:0.006042:0.005711:0.012604:0.018049:0.005330:0.003877:0.006523:0.011738:0.012508:0.005330:0.003872:0.003848:0.011738:0.006523:0.005792:0.013143:0.012450:0.012508:0.003848:0.003848:0.011699:0.003848:0.013143:0.005792:0.009217:0.012450:0.012604:0.018049:0.013123:0.013143:0.005792:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.005330
It is particularly common with leukaemias :@0.084848:0.919879:0.481076:0.919879:0.481076:0.904123:0.084848:0.904123:0.004349:0.006523:0.007139:0.003848:0.007466:0.007152:0.013123:0.013143:0.005792:0.006523:0.003848:0.012450:0.011699:0.003848:0.013143:0.005792:0.003848:0.010314:0.007152:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.007139:0.015990:0.003848:0.006523:0.011738:0.007139:0.003848:0.012508:0.011699:0.009660:0.013143:0.012508:0.018049:0.003848:0.013143:0.007466:0.005330
and lymphomas. Tumour lysis syndrome is :@0.084848:0.936270:0.481076:0.936270:0.481076:0.920514:0.084848:0.920514:0.013143:0.011738:0.013181:0.007235:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.007466:0.005330:0.007235:0.007310:0.011699:0.018049:0.012604:0.011699:0.005792:0.007224:0.003848:0.010314:0.007466:0.003848:0.007466:0.007254:0.007466:0.010314:0.011738:0.013181:0.005717:0.012604:0.018049:0.012508:0.007235:0.003848:0.007466:0.005330
associated with  high  levels of  serum  uric :@0.524249:0.096192:0.920502:0.096192:0.920502:0.080436:0.524249:0.080436:0.013143:0.007466:0.007466:0.012604:0.012450:0.003848:0.013143:0.006523:0.012508:0.013181:0.008582:0.015990:0.003848:0.006523:0.011738:0.005330:0.003238:0.011738:0.003848:0.012950:0.011738:0.005330:0.003233:0.003848:0.012508:0.010660:0.012508:0.003848:0.007466:0.008582:0.012604:0.006042:0.005330:0.003238:0.007466:0.012508:0.005792:0.011699:0.018049:0.005330:0.003235:0.011699:0.005792:0.003848:0.012450:0.005330
acid, potassium  and  phosphate.  High :@0.524249:0.112874:0.920484:0.112874:0.920484:0.097118:0.524249:0.097118:0.013143:0.012450:0.003848:0.013181:0.005330:0.015509:0.013123:0.012604:0.006523:0.013143:0.007466:0.007466:0.003848:0.011699:0.018049:0.005330:0.010168:0.013143:0.011738:0.013181:0.005330:0.010168:0.013123:0.011738:0.012604:0.007466:0.013123:0.011738:0.013143:0.006523:0.012508:0.005330:0.005330:0.010160:0.013143:0.003848:0.012950:0.011738:0.005330
levels of  phosphate  cause  secondary :@0.524249:0.129556:0.920496:0.129556:0.920496:0.113800:0.524249:0.113800:0.003848:0.012508:0.010660:0.012508:0.003848:0.007466:0.015760:0.012604:0.006042:0.005330:0.010420:0.013123:0.011738:0.012604:0.007466:0.013123:0.011738:0.013143:0.006523:0.012508:0.005330:0.010420:0.012450:0.013143:0.011699:0.007466:0.012508:0.005330:0.010418:0.007466:0.012508:0.012450:0.012604:0.011738:0.013181:0.013143:0.005792:0.010314:0.005330
hypoparathyroidism, resulting in hypo- :@0.524249:0.146238:0.920502:0.146238:0.920502:0.130482:0.524249:0.130482:0.011738:0.010314:0.013123:0.012604:0.013123:0.013143:0.005792:0.013143:0.006523:0.011738:0.010314:0.005711:0.012604:0.003848:0.013181:0.003848:0.007466:0.018049:0.005330:0.017761:0.005713:0.012508:0.007466:0.011699:0.003848:0.006523:0.003848:0.011738:0.012950:0.017761:0.003848:0.011738:0.017761:0.011738:0.010314:0.013123:0.012604:0.006388:0.005330
calcaemia. Complications of tumour lysis :@0.524249:0.162920:0.920486:0.162920:0.920486:0.147164:0.524249:0.147164:0.012450:0.013143:0.003848:0.012450:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330:0.007543:0.015644:0.012604:0.018049:0.013123:0.003848:0.003848:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.007543:0.012604:0.006042:0.007543:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007522:0.003848:0.010314:0.007466:0.003848:0.007466:0.005330
syndrome include kidney damage, hyper-:@0.524249:0.179602:0.915154:0.179602:0.915154:0.163846:0.524249:0.163846:0.007466:0.010314:0.011738:0.013181:0.005717:0.012604:0.018049:0.012508:0.005157:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.005163:0.009660:0.003848:0.013181:0.011738:0.012508:0.010314:0.005165:0.013181:0.013143:0.018049:0.013143:0.012950:0.012508:0.005330:0.005157:0.011738:0.010314:0.013123:0.012508:0.005792:0.006388
kalaemia, and  cardiac arrhythmias. Tu-:@0.524249:0.196283:0.915173:0.196283:0.915173:0.180528:0.524249:0.180528:0.009660:0.013143:0.003848:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330:0.011873:0.013143:0.011738:0.013181:0.005330:0.006533:0.012450:0.013143:0.005677:0.013181:0.003848:0.013143:0.012450:0.011873:0.013143:0.005792:0.006338:0.011738:0.010314:0.006523:0.011738:0.018049:0.003848:0.013143:0.007466:0.005330:0.011873:0.007310:0.011699:0.006388
mour lysis syndrome prophylaxis with high :@0.524249:0.212965:0.920502:0.212965:0.920502:0.197210:0.524249:0.197210:0.018049:0.012604:0.011699:0.005792:0.007139:0.003848:0.010314:0.007466:0.003848:0.007466:0.007158:0.007466:0.010314:0.011738:0.013181:0.005717:0.012604:0.018049:0.012508:0.007139:0.013123:0.005715:0.012604:0.013123:0.011738:0.010314:0.003848:0.013143:0.009236:0.003848:0.007466:0.007150:0.015990:0.003848:0.006523:0.011738:0.007139:0.011738:0.003848:0.012950:0.011738:0.005330
fluid intake, alkalisation of the urine, and :@0.524249:0.229647:0.920486:0.229647:0.920486:0.213892:0.524249:0.213892:0.004666:0.004666:0.011699:0.003848:0.013181:0.008151:0.003848:0.011738:0.006523:0.013143:0.009660:0.012508:0.005330:0.008145:0.013143:0.003848:0.009660:0.013143:0.003848:0.003848:0.007466:0.013143:0.006523:0.003848:0.012604:0.011738:0.008161:0.012604:0.006042:0.008145:0.006523:0.011738:0.012508:0.008149:0.011699:0.005792:0.003848:0.011738:0.012508:0.005330:0.008141:0.013143:0.011738:0.013181:0.005330
prophylactic allopurinol is indicated in pa-:@0.524249:0.246329:0.915168:0.246329:0.915168:0.230573:0.524249:0.230573:0.013123:0.005715:0.012604:0.013123:0.011738:0.010314:0.003848:0.013143:0.012450:0.006523:0.003848:0.012450:0.005195:0.013143:0.003848:0.003848:0.012604:0.013123:0.011699:0.005792:0.003848:0.011738:0.012604:0.003848:0.005186:0.003848:0.007466:0.005195:0.003848:0.011738:0.013181:0.003848:0.012450:0.013143:0.006523:0.012508:0.013181:0.005195:0.003848:0.011738:0.005195:0.013123:0.013143:0.006388
tients  with  a  significant  tumour-cell  load, :@0.524249:0.263011:0.920496:0.263011:0.920496:0.247255:0.524249:0.247255:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.003564:0.015990:0.003848:0.006523:0.011738:0.005330:0.003566:0.013143:0.005330:0.003568:0.007466:0.003848:0.012950:0.011738:0.003848:0.004686:0.004686:0.012450:0.013143:0.011738:0.006523:0.005330:0.003564:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.006388:0.012450:0.012508:0.003848:0.003848:0.005330:0.003566:0.003848:0.012604:0.013143:0.013181:0.005330:0.005330
particularly with haematological  malig-:@0.524249:0.279693:0.915139:0.279693:0.915139:0.263937:0.524249:0.263937:0.013123:0.013143:0.005792:0.006523:0.003848:0.012450:0.011699:0.003848:0.013143:0.005792:0.003848:0.010314:0.013547:0.015990:0.003848:0.006523:0.011738:0.013547:0.011738:0.013143:0.012508:0.018049:0.013143:0.006523:0.012604:0.003848:0.012604:0.012939:0.003848:0.012450:0.013143:0.003848:0.005330:0.008228:0.018049:0.013143:0.003848:0.003848:0.012950:0.006388
nancies. Tumour lysis syndrome is a severe :@0.524249:0.296375:0.920506:0.296375:0.920506:0.280619:0.524249:0.280619:0.011738:0.013143:0.011738:0.012450:0.003848:0.012508:0.007466:0.005330:0.005869:0.007310:0.011699:0.018049:0.012604:0.011699:0.005792:0.005852:0.003848:0.010314:0.007466:0.003848:0.007466:0.005882:0.007466:0.010314:0.011738:0.013181:0.005717:0.012604:0.018049:0.012508:0.005869:0.003848:0.007466:0.005869:0.013143:0.005869:0.007466:0.012508:0.010660:0.012508:0.005717:0.012508:0.005330
fatal complication if left untreated.:@0.524249:0.313057:0.850163:0.313057:0.850163:0.297301:0.524249:0.297301:0.006042:0.013143:0.006523:0.013143:0.003848:0.005330:0.012450:0.012604:0.018049:0.013123:0.003848:0.003848:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.003848:0.006042:0.005330:0.003848:0.012508:0.006042:0.006523:0.005330:0.011699:0.011738:0.006523:0.005702:0.012508:0.013143:0.006523:0.012508:0.013181:0.005330
46,47:@0.850151:0.307438:0.879239:0.307438:0.879239:0.298253:0.850151:0.298253:0.006215:0.006215:0.004228:0.006215:0.006215
CARDIOTOXICITY :@0.524242:0.346748:0.706403:0.346748:0.706403:0.328933:0.524242:0.328933:0.016677:0.015822:0.012401:0.014966:0.005987:0.017960:0.008980:0.017960:0.014539:0.005987:0.016677:0.005987:0.008980:0.013256:0.005987
Cardiotoxicity is typically  prominent  with :@0.524242:0.364579:0.920485:0.364579:0.920485:0.348823:0.524242:0.348823:0.015644:0.013143:0.005677:0.013181:0.003848:0.012604:0.006523:0.012604:0.009236:0.003848:0.012450:0.003848:0.006523:0.010314:0.009698:0.003848:0.007466:0.009698:0.006523:0.010314:0.013123:0.003848:0.012450:0.013143:0.003848:0.003848:0.010314:0.005330:0.004381:0.013123:0.005715:0.012604:0.018049:0.003848:0.011738:0.012508:0.011738:0.006523:0.005330:0.004358:0.015990:0.003848:0.006523:0.011738:0.005330
the use of anthracycline drugs (doxo-:@0.524242:0.381261:0.915170:0.381261:0.915170:0.365505:0.524242:0.365505:0.006523:0.011738:0.012508:0.013681:0.011699:0.007466:0.012508:0.013681:0.012604:0.006042:0.013681:0.013143:0.011738:0.006523:0.011738:0.005792:0.013143:0.012450:0.010314:0.012450:0.003848:0.003848:0.011738:0.012508:0.013681:0.013181:0.005792:0.011699:0.012950:0.007466:0.013681:0.007100:0.013181:0.012604:0.009236:0.012604:0.006388
rubicin, epirubicin, and idarubicin). This :@0.524242:0.397943:0.920462:0.397943:0.920462:0.382187:0.524242:0.382187:0.005792:0.011699:0.013123:0.003848:0.012450:0.003848:0.011738:0.005330:0.012835:0.012508:0.013123:0.003848:0.005792:0.011699:0.013123:0.003848:0.012450:0.003848:0.011738:0.005330:0.012835:0.013143:0.011738:0.013181:0.012835:0.003848:0.013181:0.013143:0.005792:0.011699:0.013123:0.003848:0.012450:0.003848:0.011738:0.007100:0.005330:0.012835:0.008197:0.011738:0.003848:0.007466:0.005330
toxicity  is cumulative. The  cause of  car-:@0.524242:0.414625:0.915167:0.414625:0.915167:0.398869:0.524242:0.398869:0.006523:0.012604:0.009236:0.003848:0.012450:0.003848:0.006523:0.010314:0.005330:0.004397:0.003848:0.007466:0.009737:0.012450:0.011699:0.018049:0.011699:0.003848:0.013143:0.006523:0.003848:0.010660:0.012508:0.005330:0.009737:0.008197:0.011738:0.012508:0.005330:0.004389:0.012450:0.013143:0.011699:0.007466:0.012508:0.009737:0.012604:0.006042:0.005330:0.004391:0.012450:0.013143:0.005792:0.006388
diotoxicity is due to the production of free :@0.524242:0.431307:0.920489:0.431307:0.920489:0.415551:0.524242:0.415551:0.013181:0.003848:0.012604:0.006523:0.012604:0.009236:0.003848:0.012450:0.003848:0.006523:0.010314:0.005494:0.003848:0.007466:0.005503:0.013181:0.011699:0.012508:0.005492:0.006523:0.012604:0.005488:0.006523:0.011738:0.012508:0.005486:0.013123:0.005715:0.012604:0.013181:0.011699:0.012450:0.006523:0.003848:0.012604:0.011738:0.005486:0.012604:0.006042:0.005490:0.006042:0.005711:0.012508:0.012508:0.005330
radicals in the  cell and subsequent  DNA :@0.524242:0.447989:0.920478:0.447989:0.920478:0.432233:0.524242:0.432233:0.005792:0.013143:0.013181:0.003848:0.012450:0.013143:0.003848:0.007466:0.008390:0.003848:0.011738:0.008390:0.006523:0.011738:0.012508:0.005330:0.003048:0.012450:0.012508:0.003848:0.003848:0.008390:0.013143:0.011738:0.013181:0.008390:0.007466:0.011699:0.013123:0.007466:0.012508:0.013123:0.011699:0.012508:0.011738:0.006523:0.005330:0.003048:0.014316:0.014239:0.014239:0.005330
damage.:@0.524242:0.464671:0.612545:0.464671:0.612545:0.448915:0.524242:0.448915:0.013181:0.013143:0.018049:0.013143:0.012950:0.012508:0.005330
48-51:@0.612543:0.459064:0.641127:0.459064:0.641127:0.449878:0.612543:0.449878:0.006215:0.006215:0.003724:0.006215:0.006215
HEPATOTOXICITY:@0.524242:0.498374:0.696996:0.498374:0.696996:0.480559:0.524242:0.480559:0.014539:0.011118:0.011973:0.015822:0.008980:0.017960:0.008980:0.017960:0.014539:0.005987:0.016677:0.005987:0.008980:0.013256
Hepatotoxicity can be caused by com-:@0.524242:0.516205:0.915170:0.516205:0.915170:0.500449:0.524242:0.500449:0.013143:0.012508:0.013123:0.013143:0.006523:0.012604:0.006523:0.012604:0.009236:0.003848:0.012450:0.003848:0.006523:0.010314:0.009640:0.012450:0.013143:0.011738:0.009640:0.013123:0.012508:0.009640:0.012450:0.013143:0.011699:0.007466:0.012508:0.013181:0.009640:0.013123:0.010314:0.009640:0.012450:0.012604:0.018049:0.006388
monly used chemotherapy drugs. Risk fac-:@0.524242:0.532887:0.915161:0.532887:0.915161:0.517131:0.524242:0.517131:0.018049:0.012604:0.011738:0.003848:0.010314:0.004387:0.011699:0.007466:0.012508:0.013181:0.004387:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.004378:0.013181:0.005792:0.011699:0.012950:0.007466:0.005330:0.004387:0.011680:0.003848:0.007466:0.009660:0.004387:0.006042:0.013143:0.012450:0.006388
tors associated with liver damage include :@0.524242:0.549569:0.920479:0.549569:0.920479:0.533813:0.524242:0.533813:0.006523:0.012604:0.005792:0.007466:0.005830:0.013143:0.007466:0.007466:0.012604:0.012450:0.003848:0.013143:0.006523:0.012508:0.013181:0.005836:0.015990:0.003848:0.006523:0.011738:0.005838:0.003848:0.003848:0.010660:0.012508:0.005792:0.005850:0.013181:0.013143:0.018049:0.013143:0.012950:0.012508:0.005834:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.005330
the primary malignant condition and met-:@0.524242:0.566251:0.915153:0.566251:0.915153:0.550495:0.524242:0.550495:0.006523:0.011738:0.012508:0.005003:0.013123:0.005792:0.003848:0.018049:0.013143:0.005792:0.010314:0.005011:0.018049:0.013143:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.006523:0.005009:0.012450:0.012604:0.011738:0.013181:0.003848:0.006523:0.003848:0.012604:0.011738:0.005003:0.013143:0.011738:0.013181:0.005011:0.018049:0.012508:0.006523:0.006388
astatic liver disease, viral hepatitis, immu-:@0.524242:0.582933:0.915119:0.582933:0.915119:0.567177:0.524242:0.567177:0.013143:0.007466:0.006523:0.013143:0.006523:0.003848:0.012450:0.007254:0.003848:0.003848:0.010660:0.012508:0.005792:0.007266:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330:0.007254:0.010660:0.003848:0.005792:0.013143:0.003848:0.007268:0.011738:0.012508:0.013123:0.013143:0.006523:0.003848:0.006523:0.003848:0.007466:0.005330:0.007254:0.003848:0.018049:0.018049:0.011699:0.006388
nosuppression  and  nutritional  deficiency. :@0.524242:0.599615:0.920487:0.599615:0.920487:0.583859:0.524242:0.583859:0.011738:0.012604:0.007466:0.011699:0.013123:0.013123:0.005713:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.005330:0.003591:0.013143:0.011738:0.013181:0.005330:0.003591:0.011738:0.011699:0.006523:0.005792:0.003848:0.006523:0.003848:0.012604:0.011738:0.013131:0.003848:0.005330:0.003594:0.013181:0.012508:0.004686:0.004686:0.012450:0.003848:0.012508:0.011738:0.012450:0.010314:0.005330:0.005330
Chemotherapy  drugs associated with :@0.524242:0.616297:0.920472:0.616297:0.920472:0.600541:0.524242:0.600541:0.015644:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.013229:0.013181:0.005792:0.011699:0.012950:0.007466:0.018569:0.013143:0.007466:0.007466:0.012604:0.012450:0.003848:0.013143:0.006523:0.012508:0.013181:0.018569:0.015990:0.003848:0.006523:0.011738:0.005330
liver toxicity include irinotecan and oxali-:@0.524242:0.632979:0.915132:0.632979:0.915132:0.617223:0.524242:0.617223:0.003848:0.003848:0.010660:0.012508:0.005792:0.007658:0.006523:0.012604:0.009236:0.003848:0.012450:0.003848:0.006523:0.010314:0.007658:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.007658:0.003848:0.005792:0.003848:0.011738:0.012604:0.006523:0.012508:0.012450:0.013143:0.011738:0.007658:0.013143:0.011738:0.013181:0.007658:0.012604:0.009236:0.013143:0.003848:0.003848:0.006388
platin. Hepatotoxicity includes damage to :@0.524242:0.649661:0.920501:0.649661:0.920501:0.633905:0.524242:0.633905:0.013123:0.003848:0.013143:0.006523:0.003848:0.011738:0.005330:0.004541:0.013143:0.012508:0.013123:0.013143:0.006523:0.012604:0.006523:0.012604:0.009236:0.003848:0.012450:0.003848:0.006523:0.010314:0.004541:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.007466:0.004532:0.013181:0.013143:0.018049:0.013143:0.012950:0.012508:0.004532:0.006523:0.012604:0.005330
hepatocyte, hepatic sinusoidal syndrome, :@0.524242:0.666343:0.920476:0.666343:0.920476:0.650587:0.524242:0.650587:0.011738:0.012508:0.013123:0.013143:0.006523:0.012604:0.012450:0.010314:0.006523:0.012508:0.005330:0.005013:0.011738:0.012508:0.013123:0.013143:0.006523:0.003848:0.012450:0.005022:0.007466:0.003848:0.011738:0.011699:0.007466:0.012604:0.003848:0.013181:0.013143:0.003848:0.005022:0.007466:0.010314:0.011738:0.013181:0.005719:0.012604:0.018049:0.012508:0.005330:0.005330
cholestasis and liver fibrosis.:@0.524242:0.683024:0.778936:0.683024:0.778936:0.667269:0.524242:0.667269:0.012450:0.011738:0.012604:0.003848:0.012508:0.007466:0.006523:0.013143:0.007466:0.003848:0.007466:0.005330:0.013143:0.011738:0.013181:0.005330:0.003848:0.003848:0.010660:0.012508:0.005792:0.005330:0.004686:0.004686:0.013123:0.005717:0.012604:0.007466:0.003848:0.007466:0.005330
52:@0.778941:0.677425:0.791371:0.677425:0.791371:0.668240:0.778941:0.668240:0.006215:0.006215
NEPHROTOXICITY:@0.524242:0.716736:0.700417:0.716736:0.700417:0.698920:0.524242:0.698920:0.015822:0.011118:0.011973:0.014539:0.012401:0.017960:0.008980:0.017960:0.014539:0.005987:0.016677:0.005987:0.008980:0.013256
Nephrotoxicity can be caused by tu-:@0.524242:0.734566:0.915149:0.734566:0.915149:0.718810:0.524242:0.718810:0.014624:0.012892:0.013508:0.012123:0.006098:0.012989:0.006908:0.012989:0.009621:0.004233:0.012835:0.004233:0.006908:0.010699:0.012604:0.012835:0.013527:0.012123:0.012604:0.013508:0.012892:0.012604:0.012835:0.013527:0.012084:0.007851:0.012892:0.013566:0.012604:0.013508:0.010699:0.012604:0.006908:0.012084:0.006388
mour lysis syndrome, pre-renal dehydra-:@0.524242:0.751248:0.915151:0.751248:0.915151:0.735492:0.524242:0.735492:0.018434:0.012989:0.012084:0.006177:0.007235:0.004233:0.010699:0.007851:0.004233:0.007851:0.007226:0.007851:0.010699:0.012123:0.013566:0.006098:0.012989:0.018434:0.012892:0.005715:0.007226:0.013508:0.006096:0.012892:0.006773:0.006096:0.012892:0.012123:0.013527:0.004233:0.007226:0.013566:0.012892:0.012123:0.010699:0.013566:0.006177:0.013527:0.006388
tion, direct effects of chemotherapy :@0.524242:0.767930:0.920535:0.767930:0.920535:0.752174:0.524242:0.752174:0.006908:0.004233:0.012989:0.012123:0.005715:0.015509:0.013566:0.004233:0.006096:0.012892:0.012835:0.006908:0.015509:0.012892:0.006483:0.006427:0.012892:0.012835:0.006908:0.007851:0.015509:0.012989:0.006427:0.015509:0.012835:0.012123:0.012892:0.018434:0.012989:0.006908:0.012123:0.012892:0.006177:0.013527:0.013508:0.010316:0.005330
drug in the kidneys, tubular damage and :@0.524242:0.784612:0.920481:0.784612:0.920481:0.768856:0.524242:0.768856:0.013566:0.006177:0.012084:0.013335:0.004618:0.004233:0.012123:0.004618:0.006908:0.012123:0.012892:0.004618:0.010045:0.004233:0.013566:0.012123:0.012892:0.010699:0.007851:0.005715:0.004618:0.006908:0.012084:0.013508:0.012084:0.004233:0.013527:0.006177:0.004618:0.013566:0.013527:0.018434:0.013527:0.013335:0.012892:0.004618:0.013527:0.012123:0.013181:0.005330
obstructive uropathy. Cisplatin is particu-:@0.524242:0.801294:0.915142:0.801294:0.915142:0.785538:0.524242:0.785538:0.012989:0.013508:0.007851:0.006908:0.006177:0.012084:0.012835:0.006908:0.004233:0.011045:0.012892:0.004857:0.012084:0.006098:0.012989:0.013508:0.013527:0.006908:0.012123:0.010699:0.005715:0.004857:0.016029:0.004233:0.007851:0.013508:0.004233:0.013527:0.006908:0.004233:0.012123:0.004857:0.004233:0.007851:0.004857:0.013508:0.013527:0.006177:0.006908:0.004233:0.012835:0.012084:0.006388
larly nephrotoxic and may induce acute :@0.524242:0.817976:0.920516:0.817976:0.920516:0.802220:0.524242:0.802220:0.004233:0.013527:0.006177:0.004233:0.010699:0.005657:0.012123:0.012892:0.013508:0.012123:0.006098:0.012989:0.006908:0.012989:0.009621:0.004233:0.012835:0.005657:0.013527:0.012123:0.013566:0.005657:0.018434:0.013527:0.010699:0.005657:0.004233:0.012123:0.013566:0.012084:0.012835:0.012892:0.005657:0.013527:0.012835:0.012084:0.006908:0.012506:0.005330
renal failure.:@0.524242:0.834658:0.643656:0.834658:0.643656:0.818902:0.524242:0.818902:0.006098:0.012892:0.012123:0.013527:0.004233:0.005715:0.006427:0.013527:0.004233:0.004233:0.012084:0.006098:0.012892:0.005330
53-55:@0.644041:0.829051:0.673523:0.829051:0.673523:0.819865:0.644041:0.819865:0.006439:0.006439:0.003949:0.006439:0.006215
OTOTOXICITY :@0.524242:0.868361:0.667491:0.868361:0.667491:0.850546:0.524242:0.850546:0.017960:0.008980:0.017960:0.008980:0.017960:0.014539:0.005987:0.016677:0.005987:0.008980:0.013256:0.005987
Ototoxicity to the inner ear is a common :@0.524242:0.886192:0.920481:0.886192:0.920481:0.870436:0.524242:0.870436:0.016722:0.006523:0.012604:0.006523:0.012604:0.009236:0.003848:0.012450:0.003848:0.006523:0.010314:0.007543:0.006523:0.012604:0.007543:0.006523:0.011738:0.012508:0.007543:0.003848:0.011738:0.011738:0.012508:0.005792:0.007543:0.012508:0.013143:0.005792:0.007543:0.003848:0.007466:0.007543:0.013143:0.007543:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.005330
side effect  of platinum-based  agents. :@0.524242:0.902874:0.920503:0.902874:0.920503:0.887118:0.524242:0.887118:0.007466:0.003848:0.013181:0.012508:0.015432:0.012508:0.006096:0.006042:0.012508:0.012450:0.006523:0.005330:0.010087:0.012604:0.006042:0.015432:0.013123:0.003848:0.013143:0.006523:0.003848:0.011738:0.011699:0.018049:0.006388:0.013123:0.013143:0.007480:0.012508:0.013181:0.005330:0.010091:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.005330:0.005330
Ototoxicity  symptoms  include  dizziness :@0.524242:0.919556:0.920468:0.919556:0.920468:0.903800:0.524242:0.903800:0.016722:0.006523:0.012604:0.006523:0.012604:0.009236:0.003848:0.012450:0.003848:0.006523:0.010314:0.005330:0.011474:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.007466:0.005330:0.011478:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.005330:0.011478:0.013181:0.003848:0.008178:0.008178:0.003848:0.011738:0.012508:0.007466:0.007466:0.005330
and vertigo.:@0.524242:0.936238:0.637849:0.936238:0.637849:0.920482:0.524242:0.920482:0.013143:0.011738:0.013181:0.005330:0.010660:0.012508:0.005792:0.006523:0.003848:0.012950:0.012604:0.005330
55,56:@0.637836:0.930625:0.666924:0.930625:0.666924:0.921439:0.637836:0.921439:0.006215:0.006215:0.004228:0.006215:0.006215